Lactosucrose Attenuates Intestinal Inflammation by Promoting Th2 Cytokine Production and Enhancing Cd86 Expression in Colitic Rats

Yan Zhou,Zheng Ruan,Xiaoli Zhou,Xiaoliu Huang,Hua Li,Ling Wang,Cui Zhang,Zeyuan Deng,Guoyao Wu,Yulong Yin
DOI: https://doi.org/10.1080/09168451.2014.991680
2015-01-01
Bioscience Biotechnology and Biochemistry
Abstract:Some oligosaccharides have immunoregulatory and anti-inflammatory functions in the intestine. This study investigated the immunoregulatory effect of lactosucrose (LS) on 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitic rats. Alkaline phosphatase activity was increased but myeloperoxidase activity was decreased in the LS-TNBS group, as compared with the TNBS group (colitis rats without receiving LS). LS supplementation stimulated IL-4 and IL-10 production, while up-regulating CD86 expression in dendritic cells. LS supplementation reduced the ratio of CD80/CD86 and the ratio of IFN-γ/IL-4 compared to the TNBS group. Moreover, IFN-γ was significantly correlated with CD80 (r = 0.764, p < 0.01), whereas IL-4 was significantly correlated with CD86 (r = 0.489, p < 0.05). These results indicated that LS attenuated colitis by promoting the production of Th2-type cytokines and rebalancing the ratio of Th1/Th2 and that enhanced IL-4 production is correlated with enhanced CD86 expression in the gut. Therefore, LS is a functional food for patients with inflammatory bowel disease. LS attenuated TNBS-induced colitis by promoting the production of Th2-type cytokines and rebalancing the ratio of Th1/Th2. And the enhanced IL-4 production is correlated with enhanced CD86 expression.
What problem does this paper attempt to address?